Zydus Wellness Management

Management criteria checks 4/4

Zydus Wellness' CEO is Tarun Arora, appointed in Jan 2019, has a tenure of 5.33 years. total yearly compensation is ₹12.54M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth ₹3.33M. The average tenure of the management team and the board of directors is 5.3 years and 6.4 years respectively.

Key information

Tarun Arora

Chief executive officer

₹12.5m

Total compensation

CEO salary percentage	100.0%
CEO tenure	5.3yrs
CEO ownership	0.003%
Management average tenure	5.3yrs
Board average tenure	6.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tarun Arora's remuneration changed compared to Zydus Wellness's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹3b
Sep 30 2023	n/a	n/a	₹3b
Jun 30 2023	n/a	n/a	₹3b
Mar 31 2023	₹13m	₹13m	₹3b
Dec 31 2022	n/a	n/a	₹3b
Sep 30 2022	n/a	n/a	₹3b
Jun 30 2022	n/a	n/a	₹3b
Mar 31 2022	₹12m	₹12m	₹3b
Dec 31 2021	n/a	n/a	₹3b
Sep 30 2021	n/a	n/a	₹3b
Jun 30 2021	n/a	n/a	₹2b
Mar 31 2021	₹13m	₹13m	₹1b
Dec 31 2020	n/a	n/a	₹547m
Sep 30 2020	n/a	n/a	₹572m
Jun 30 2020	n/a	n/a	₹2b
Mar 31 2020	₹11m	₹11m	₹1b
Dec 31 2019	n/a	n/a	₹1b
Sep 30 2019	n/a	n/a	₹2b
Jun 30 2019	n/a	n/a	₹2b
Mar 31 2019	₹33m	₹33m	₹2b
Dec 31 2018	n/a	n/a	₹1b
Sep 30 2018	n/a	n/a	₹1b
Jun 30 2018	n/a	n/a	₹1b
Mar 31 2018	₹30m	₹30m	₹1b

Compensation vs Market: Tarun's total compensation ($USD150.25K) is below average for companies of similar size in the Indian market ($USD433.43K).

Compensation vs Earnings: Tarun's compensation has been consistent with company performance over the past year.

CEO

Tarun Arora (51 yo)

5.3yrs

Tenure

₹12,542,000

Compensation

Mr. Tarun G. Arora has been Chief Executive Officer of Zydus Wellness Limited since January 2019 and is instrumental in accelerating the growth on back of innovations, expanding the geographies for the bus...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Tarun Arora	CEO & Whole Time Director	5.3yrs	₹12.54m	0.0031% ₹ 3.3m
Umesh Parikh	Chief Financial Officer	6.3yrs	₹12.02m	no data
Nandish Joshi	Company Secretary	1.8yrs	no data	no data

5.3yrs

Average Tenure

Experienced Management: 531335's management team is seasoned and experienced (5.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Tarun Arora	CEO & Whole Time Director	9yrs	₹12.54m	0.0031% ₹ 3.3m
Sharvil Patel	Non-Executive Chairman	15.1yrs	₹800.00k	0.00084% ₹ 891.7k
Ganesh Nayak	Non-Executive Director	17.8yrs	₹1.20m	0.010% ₹ 10.9m
Dharmishtaben Raval	Non-Executive Independent Director	5.2yrs	₹1.40m	no data
Kulin Lalbhai	Non-Executive & Independent Director	7.5yrs	₹1.70m	no data
Akhil Monappa	Additional Non Executive & Independent Director	less than a year	no data	no data
Ashish Bhargava	Nominee Director	5.3yrs	no data	no data
Srivishnu Nandyala	Non-Executive Independent Director	5.2yrs	₹1.70m	no data

6.4yrs

Average Tenure

50yo

Average Age

Experienced Board: 531335's board of directors are considered experienced (6.4 years average tenure).

Zydus Wellness Management

Management criteria checks 4/4

Key information

Recent management updates

Insider recently bought ₹175m worth of stock

Zydus Wellness Limited Announces Resignation of Savyasachi Sengupta as Independent Director

Insider recently bought ₹331m worth of stock

Insider recently bought ₹385m worth of stock

Insider recently bought ₹148m worth of stock

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Recent updates

Insider recently bought ₹175m worth of stock

Consensus EPS estimates fall by 15%

Third quarter 2024 earnings released: EPS: ₹0.05 (vs ₹3.07 in 3Q 2023)

Zydus Wellness Limited to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: EPS: ₹0.93 (vs ₹1.33 in 2Q 2023)

Zydus Wellness Limited Announces Resignation of Savyasachi Sengupta as Independent Director

Zydus Wellness Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently bought ₹331m worth of stock

Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2023

New minor risk - Dividend sustainability

Zydus Wellness Limited to Report Q1, 2024 Results on Aug 03, 2023

Upcoming dividend of ₹5.00 per share at 0.3% yield

Full year 2023 earnings: EPS misses analyst expectations

Insider recently bought ₹385m worth of stock

Insider recently bought ₹148m worth of stock

Price target decreased by 7.4% to ₹1,813

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Zydus Wellness Limited Appoints Akhil Monappa as Additional Director (Non Executive & Independent Director)

Full year 2023 earnings: EPS misses analyst expectations

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Insider recently bought ₹1.8m worth of stock

Third quarter 2023 earnings released: EPS: ₹3.07 (vs ₹3.66 in 3Q 2022)

CEO & Whole Time Director recently bought ₹301k worth of stock

Second quarter 2023 earnings released: EPS: ₹1.33 (vs ₹3.37 in 2Q 2022)

Insider recently bought ₹16m worth of stock

Insider recently bought ₹9.2m worth of stock

Zydus Wellness Limited Declares Final Dividend for the Financial Year Ended March 31, 2022

Zydus Wellness Limited Appoints Nandish P. Joshi as the Company Secretary

Upcoming dividend of ₹5.00 per share

Zydus Wellness Limited to Report First Half, 2023 Results on Nov 14, 2022

Insider recently bought ₹55m worth of stock

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Zydus Wellness Limited Recommends Final Dividend for the Year Ended on March 31, 2022, Payable on or After August 4, 2022

Consensus forecasts updated

Zydus Wellness Limited, Annual General Meeting, Jul 29, 2022

Price target decreased to ₹2,125

Insufficient new directors

Price target decreased to ₹2,125

Insufficient new directors

Insider recently bought ₹757k worth of stock

Zydus Wellness Limited Announces Resignation of Dhanraj P. Dagar as Company Secretary & Compliance Officer, Effective May 10, 2022

Consensus EPS estimates fall by 10%

Price target decreased to ₹2,339

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

CEO & Whole Time Director recently bought ₹812k worth of stock

Second quarter 2022 earnings released: EPS ₹3.37 (vs ₹18.14 loss in 2Q 2021)

Insider recently sold ₹2.3m worth of stock

Price target increased to ₹2,517

Upcoming dividend of ₹5.00 per share

Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020)

Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020)

Zydus Wellness Limited Recommends Final Dividend

Price target raised to ₹2,266

Third quarter 2021 earnings released: EPS ₹0.27 (vs ₹0.73 in 3Q 2020)

Revenue beats expectations, earnings disappoint

Zydus Announces United States Food and Drug Administration (USFDA) Has Granted `Orphan Drug Designation' (ODD) to Saroglitazar Mg for the Treatment of Patients with Primary Biliary Cholangitis

Zydus Wellness Limited to Report Q3, 2021 Results on Feb 01, 2021

New 90-day high: ₹1,940

New 90-day high: ₹1,919

Price target raised to ₹2,039

Second quarter 2021 earnings released: ₹18.14 loss per share

Revenue and earnings miss expectations

Price target raised to ₹1,877

Zydus Wellness Limited has completed a Follow-on Equity Offering in the amount of INR 6.49974 billion.

Zydus Wellness Limited announced a financing transaction

Zydus Wellness Limited to Report Q1, 2021 Results on Jul 31, 2020

Zydus Wellness Limited Provides Operational Update

CEO Compensation Analysis

CEO